Senior corporate executive and investor focused on healthcare and consumer sectors, known for leading strategy, M&A and operational transformation. Annette M. Marshall brings leadership across private equity-backed and public companies, with board experience, capital-allocation oversight and growth execution. Background combines finance and operations with an MBA-level education; routinely advises management on scaling, cost optimisation, exit readiness and cross-border transactions.
Senior corporate executive and investor focused on healthcare and consumer sectors, known for leading strategy, M&A and operational transformation. Annette M. Marshall brings leadership across private equity-backed and public companies, with board experience, capital-allocation oversight and growth execution. Background combines finance and operations with an MBA-level education; routinely advises management on scaling, cost optimisation, exit readiness and cross-border transactions.
Combines an operationally-focused, value-oriented approach to investing in healthcare and consumer businesses. Prefers control or active minority positions where strategic and operational levers can accelerate revenue growth, margin expansion and exit value. Emphasizes rigorous diligence on commercial models, regulatory pathways and cross-border integration, and prioritizes disciplined capital allocation, milestone-based capital deployment and clear exit planning. Investment horizon is medium-to-long term, balancing growth investments with cost optimization and de-risking through staged financing and board-level governance to protect downside and maximize returns.
Combines an operationally-focused, value-oriented approach to investing in healthcare and consumer businesses. Prefers control or active minority positions where strategic and operational levers can accelerate revenue growth, margin expansion and exit value. Emphasizes rigorous diligence on commercial models, regulatory pathways and cross-border integration, and prioritizes disciplined capital allocation, milestone-based capital deployment and clear exit planning. Investment horizon is medium-to-long term, balancing growth investments with cost optimization and de-risking through staged financing and board-level governance to protect downside and maximize returns.
| Trades 2076 | Longs Won 1432/2076 68% | Profit Factor 8.45 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.28M |
| Average Win $739,443.93 | Best Trade (Aug 14) $173.96M | Sharpe Ratio -482.4 |
| Average Loss -$194,650.95 | Worst Trade (Mar 31) -$17.53M | Z-Score -0.1 (7.96%) |
| Commissions $0 | Avg. Trade Length 1y 4d | Expectancy $449,676.54 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 15,385 | 13,846 | 12,308 | 10,769 | 9,231 | 7,692 | 6,154 | 4,615 | 3,077 | 1,538 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 125,597 | $24.62M | $38.3M | - | $13.68M | 55.57% | -1.087% |
ABBV AbbVie Inc. | 24,065 | $5.23M | $5.97M | - | $733,501.09 | 14.01% | 0.0 |
ABT Abbott Laboratories | 61,021 | $7.01M | $6.7M | - | -$314,241.94 | -4.48% | +1.013% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 121,980 | $6.32M | $9.4M | - | $3.08M | 48.69% | 0.0 |
ADI Analog Devices, Inc. | 27,327 | $5.65M | $10.49M | - | $4.84M | 85.7% | -0.001% |
ADP Automatic Data Processing Inc. | 22,338 | $5.2M | $6.11M | - | $909,311.53 | 17.47% | -0.002% |
ADSK Autodesk, Inc. | 7,467 | $1.84M | $1.91M | - | $74,032.15 | 4.03% | 0.0 |
AFL Aflac Inc. | 49,604 | $5.82M | $6.05M | - | $232,642.76 | 4% | 0.0 |
AMAT Applied Materials, Inc. | 2,200 | $362,600.37 | $1.15M | - | $786,063.63 | 216.79% | 0.0 |
AMD Advanced Micro Devices, Inc. | 662 | $384,562 | $310,848.72 | - | -$73,713.28 | -19.17% | 0.0 |
AMGN Amgen Inc. | 27,727 | $8.64M | $11.57M | - | $2.93M | 33.92% | 0.0 |
AMT American Tower Corporation | 6,205 | $1.07M | $1.05M | - | -$21,531.41 | -2.01% | 0.0 |
AMZN Amazon.com Inc | 112,845 | $19.56M | $30.72M | - | $11.17M | 57.1% | -2.093% |
ANET Arista Networks, Inc. | 40,495 | $4.48M | $8.01M | - | $3.54M | 78.97% | +3.305% |
APA APA Corporation | 98,433 | $4.13M | $4.04M | - | -$91,885.98 | -2.23% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 262 | $521,233 | $471,437.56 | - | -$49,795.44 | -9.55% | +3.802% |
AVGO Broadcom Inc. | 75,279 | $23.3M | $31.8M | - | $8.5M | 36.47% | 0.0 |
AXP American Express Company | 6,362 | $1.21M | $2.16M | - | $944,583.29 | 77.98% | 0.0 |
AZN AstraZeneca PLC American Depositary Shares | 29,158 | $5.75M | $4.63M | - | -$1.12M | -19.51% | -1.952% |
BAC Bank of America Corporation | 226,467 | $8.41M | $14.46M | - | $6.05M | 71.93% | 0.0 |